Inventor · disambiguated record
Donald Middleton
Also filed as: MIDDLETON DONALD S · MIDDLETON DONALD STUART · MIDDLETON Donald
26 granted patents·5 pending applications·439 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
31 records- 0197US9718827B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2016·Granted Aug 1, 2017·22 cites·6 claims
- 0297US9340546B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 17, 2016·57 cites·6 claims
- 0396US6660756B2N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidasePFIZER·Filed 2002·Granted Dec 9, 2003·92 cites·23 claims
- 0494US9650381B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted May 16, 2017·19 cites·82 claims
- 0594US6630504B2Phenoxyphenylheterocyclyl derivatives as SSRIsPFIZER·Filed 2001·Granted Oct 7, 2003·57 cites·16 claims
- 0693US10787452B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Sep 29, 2020·5 cites·20 claims
- 0793US6448293B1Diphenyl ether compounds useful in therapyPFIZER·Filed 2001·Granted Sep 10, 2002·35 cites·28 claims
- 0890US2025223292A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0989US11117900B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2019·Granted Sep 14, 2021·2 cites·17 claims
- 1088US10392391B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 1187US11370798B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·13 claims
- 1287US6200978B1Compounds as delta opioid agonistsPFIZER·Filed 1999·Granted Mar 13, 2001·80 cites·16 claims
- 1382US12187731B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 1471US6610747B2Phenoxybenzylamine derivatives as SSRIsPFIZER·Filed 2001·Granted Aug 26, 2003·6 cites·39 claims
- 1564US7141586B2Nicotinamide derivatives useful as PDE4 inhibitorsPFIZER·Filed 2004·Granted Nov 28, 2006·2 cites·13 claims
- 1664US7129234B2Phenyl heterocyclyl ethersPFIZER·Filed 2003·Granted Oct 31, 2006·2 cites·18 claims
- 1764US6800652B2Diaryl compoundsPFIZER·Filed 2003·Granted Oct 5, 2004·2 cites·11 claims
- 1863US6262046B1Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonistsPFIZER·Filed 1998·Granted Jul 17, 2001·20 cites·22 claims
- 1959US6849649B2N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidasePFIZER·Filed 2003·Granted Feb 1, 2005·1 cites·3 claims
- 2050US6242438B13-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonistsPFIZER·Filed 1996·Granted Jun 5, 2001·10 cites·16 claims
- 2150US2005026920A1Diaryl compoundsPFIZER·Filed 2004·Application pending·0 cites
- 2249US5968923A(Azetidin-1-ylalkyl) lactams as tachykinin antagonistsPFIZER·Filed 1995·Granted Oct 19, 1999·10 cites·12 claims
- 2345US2003207857A1Phenyl heterocyclyl ethersFiled 2002·Application pending·0 cites
- 2443US7060836B2Lactams as tachykinin antagonistsPFIZER·Filed 2002·Granted Jun 13, 2006·0 cites·22 claims
- 2542US6262075B1Piperidone tachykinin antagonistsPFIZER·Filed 1997·Granted Jul 17, 2001·5 cites·17 claims
- 2642US5846965A3-aza and 3-oxa piperidone tachykinin antagonistsPFIZER·Filed 1997·Granted Dec 8, 1998·5 cites·9 claims
- 2739US2005043300A1Piperazine derivativesPFIZER·Filed 2004·Application pending·0 cites
- 2839US2009264425A1Chemical compoundsPFIZER LTD·Filed 2005·Application pending·0 cites
- 2935US6034082A5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonistsPFIZER·Filed 1996·Granted Mar 7, 2000·2 cites·8 claims
- 3029US6022971AAzetidinesPFIZER·Filed 1998·Granted Feb 8, 2000·0 cites·1 claims
- 3129US5741790AAzetidinesPFIZER·Filed 1997·Granted Apr 21, 1998·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Donald Middleton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →